---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-111298"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2025-11-17T23:59:59+00:00"
generated_at: "2026-05-16T19:07:29.240559+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oramed adopts poison pill; declares dividend of one Right per share

## Summary
- Rights trigger at 15% beneficial ownership; each Right allows purchase of one share at $10.00.
- Dividend payable Nov 27, 2025 to holders of record Nov 27, 2025; Rights expire in 3 years.
- Board may redeem Rights at $0.012 per Right prior to triggering event; distribution is not taxable.
- Rights plan designed to protect against hostile takeovers and ensure fair treatment of shareholders.

## SEC filing metadata
- accession: 0001213900-25-111298
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2025-11-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390025111298/0001213900-25-111298-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390025111298/ea0265959-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-111298
- JSON: https://secwatch.observer/filing/0001213900-25-111298.json
- Plain text: https://secwatch.observer/filing/0001213900-25-111298.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.